Open AccessStudy of the efficiency and safety of Ladasten therapy in patients with cardiovascular disease
Author(s) -
F. Yu. Kopylov,
Yu.M. Nikitina,
E. A Makukh,
А. Л. Сыркин
Publication year - 2010
Publication title -
cardiosomatika
Language(s) - English
Resource type - Journals
eISSN - 2658-5707
pISSN - 2221-7185
DOI - 10.26442/cs44966
Subject(s) - tolerability , disease , medicine , intensive care medicine , pharmacotherapy , physical therapy , adverse effect
A trial was carried out to study the efficiency and safety of therapy with the new antiasthenic drug Ladasten. The findings suggest its high safety and efficiency and good tolerability of Ladasten in the treatment of asthenia and asthenic spectrum disorders, the development of which is associated with cardiovascular disease.